Skip to content

Clinical trials

Phase 2 Myocardial Ischemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Ischemia Phase: Phase 2 Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20044
20053
20065
20075
20083
20092
20101
20113
20125
20131
20144
20155
20164
20171
20182
20192
20211
20222
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Unknown status11
Terminated4
Withdrawn4
Recruiting3
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)8
Amaranth Medical Inc.4
Cytori Therapeutics2
Instituto de Cardiologia do Rio Grande do Sul2
Medispec2
Meshalkin Research Institute of Pathology of Circulation2
Abbott Medical Devices1
Adenobio N.V1
Akiva Mintz1
Avant Immunotherapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Ischemia71
Coronary Artery Disease23
Coronary Disease19
Cardiovascular Diseases18
Myocardial Infarction17
Heart Diseases14
Angina Pectoris11
Heart Failure6
Acute Coronary Syndrome4
Inflammation4

Trials

Showing 51 to 71 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.